Sanofi

Lebanon struggles with its first cholera outbreak since 1993, as poverty, poor living conditions, and a weak health system put thousands of people at risk

A century after the discovery of insulin, quality-assured access remains hindered by high prices. The WHO resolution for transparency in pricing of insulin aims at dealing with Big Pharma market monopoly